Pneumonia in Immunocompromised Patients

The number of immunocompromised patients has increased over the past decades due to HIV infection, solid and stem cell transplantation, intensified chemotherapy and treatment of autoimmune disease. Pneumonia is a major cause of both morbidity and mortality in immunocompromised patients. Clinical management of pneumonia is difficult, since differential diagnosis in this setting is broad and includes both infectious and noninfectious processes. Because the development of pneumonia in immunocompromised patients is frequently life threatening, early therapeutic and diagnostic intervention is essential to obtain better outcomes.

keywords: Pneumonia, Immunocompromised Patient, Disease Management, Pneumonia, Immunocompromised Patient, Disease Management

Reference

1. Safadi AR, Soubani AO. Diagnostic approach of pulmonary disease in the HIV negative immunocompromised host. Eur J Intern Med 2009;20:268-79.

2. Cunha BA. Pneumonias in the compromised host. Infect Dis Clin North Am 2001;15:591-612.

3. Gasink LB, Blumberg EA. Bacterial and mycobacterial pneumonia in transplant recipients. Clin Chest Med 2005;26:647-59.

4. Baughman RP. The lung in the immunocompromised patient. Infectious complications Part 1. Respiration 1999;66:95-109.

5. Chakinala MM, Trulock EP. Pneumonia in the solid organ transplant patient. Clin Chest Med 2005;26:113-21.

6. Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 2004;125:712- 22.

7. Hayden, Randall T. Diagnostic microbiology of the immunocompromised host. Washington, D.C: ASM Press; 2009.

8. Corti M, Palmero D, Eiguchi K. Respiratory infections in immunocompromised patients. Curr Opin Pulm Med 2009;15:209-17.

바로가기메뉴

Article Contents

Vol.70 No.5

Pneumonia in Immunocompromised Patients

Abstract

Reference

Tuberculosis & Respiratory Diseases